MicrobiologybioRxiv
Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza
C. Scott, J. Kankanala, T. L. Foster…·S. Griffin
The paper identifies M2-N31 inhibitors that show synergistic antiviral effects when combined with existing drugs, offering a strategy to combat rimantadine-resistant influenza.
DOI 10.1371/journal.ppat.1008716